Application 019967
- Type
- NDA
- Sponsor
- SUN PHARM INDS INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ULTRAVATE | HALOBETASOL PROPIONATE | CREAM;TOPICAL | 0.05% | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N019967-001 | ULTRAVATE | HALOBETASOL PROPIONATE | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CREAM / TOPICAL | RLD | 1990-12-27 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | N019967-001 | ULTRAVATE | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CREAM / TOPICAL | RLD | 1990-12-27 | f41ea6bd6efb… | |
| 2022-09-29 23:25 UTC | 2022-09 | N019967-001 | ULTRAVATE | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CREAM / TOPICAL | RLD | 1990-12-27 | e64feba35796… | |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N019967-001 | ULTRAVATE | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CREAM / TOPICAL | RLD | 1990-12-27 | cb3db0bc1861… | |
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | N019967-001 | ULTRAVATE | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CREAM / TOPICAL | RLD | 1990-12-27 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N019967-001 | AB | 1 | 74a2ff9319b5… |
| 2019-09-15 20:21 UTC | 2019-09 | N019967-001 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N019967-001 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Halobetasol Propionate | HALOBETASOL PROPIONATE | Coral Way Pharma, LLC | 4cb1f7b3-c412-6fc7-e063-6394a90a63c9 | 2026-06-29 | Warnings, Adverse reactions | HALOBETASOL PROPIONATE |
| Halobetasol Propionate | HALOBETASOL PROPIONATE | Encube Ethicals, Inc. | d4f03a79-3d5e-4a39-8ab0-8ebd3d804e39 | 2026-06-29 | Adverse reactions | HALOBETASOL PROPIONATE |
| Halobetasol Propionate | HALOBETASOL PROPIONATE | Bryant Ranch Prepack | e408184b-0545-4728-9f95-90d8cdec544a | 2026-04-23 | Adverse reactions | HALOBETASOL PROPIONATE |
| LEXETTE | HALOBETASOL PROPIONATE | Mayne Pharma | 8aa1f819-c81f-4af1-aaa7-353df3203ff6 | 2025-05-31 | Warnings, Adverse reactions | HALOBETASOL PROPIONATE |
| ULTRAVATE | HALOBETASOL PROPIONATE | Lacer Pharma, LLC | 74e899db-1c1f-48b2-9913-5d32a14906ae | 2025-04-06 | Warnings, Adverse reactions | ULTRAVATE HALOBETASOL PROPIONATE |
| Halobetasol Propionate | HALOBETASOL PROPIONATE | Bryant Ranch Prepack | 83725d7b-0788-4903-a75a-8e318ee7b568 | 2024-10-24 | Adverse reactions | HALOBETASOL PROPIONATE |
| Halobetasol Propionate | HALOBETASOL PROPIONATE | Bryant Ranch Prepack | e78c7fc9-34ba-4162-a98e-78931dc31dab | 2024-08-22 | Adverse reactions | HALOBETASOL PROPIONATE |
| Halobetasol Propionate | HALOBETASOL PROPIONATE | Bryant Ranch Prepack | 14766ad1-d61d-4838-92e1-849a929f4dbd | 2024-05-29 | Adverse reactions | HALOBETASOL PROPIONATE |
| Halobetasol Propionate | HALOBETASOL PROPIONATE | Cosette Pharmaceuticals, Inc. | f12ff257-dd77-4f9c-97c4-339784772d9f | 2024-04-16 | Adverse reactions | HALOBETASOL PROPIONATE |
| Halobetasol Propionate | HALOBETASOL PROPIONATE | Bryant Ranch Prepack | be683823-9c07-498c-8357-71cbb3a3964c | 2024-03-11 | Adverse reactions | HALOBETASOL PROPIONATE |
| Halobetasol propionate | HALOBETASOL PROPIONATE | Mayne Pharma | 24c41e6d-a314-4984-b45f-e5aa1fffa9b6 | 2023-11-30 | Warnings, Adverse reactions | HALOBETASOL PROPIONATE |
| Halobetasol Propionate | HALOBETASOL PROPIONATE | Cosette Pharmaceuticals, Inc. | 1f57aaae-8d5f-bfdf-08d6-495b84221311 | 2023-11-23 | Adverse reactions | HALOBETASOL PROPIONATE |
| Halobetasol Propionate | HALOBETASOL PROPIONATE | Bryant Ranch Prepack | c4e78fa5-6ced-4c90-89c6-31e5fc71b837 | 2023-08-15 | Adverse reactions | HALOBETASOL PROPIONATE |
| Halobetasol Propionate | HALOBETASOL PROPIONATE | QUAGEN PHARMACEUTICALS LLC | fd4ebec1-e5ba-46cc-9627-4645a7b3bf19 | 2023-02-02 | Adverse reactions | HALOBETASOL PROPIONATE |
| Halobetasol Propionate | HALOBETASOL PROPIONATE | Padagis Israel Pharmaceuticals Ltd | c420da92-a3e3-4760-8cad-e50cbacebfeb | 2022-12-31 | Adverse reactions | HALOBETASOL PROPIONATE |
| Halobetasol Propionate | HALOBETASOL PROPIONATE | Padagis Israel Pharmaceuticals Ltd | df26430c-8182-4d03-a254-06d913de4c95 | 2022-12-01 | Adverse reactions | HALOBETASOL PROPIONATE |
| Bryhali | HALOBETASOL PROPIONATE | Bausch Health US, LLC | d4bbb66a-3f9d-4091-b1b0-1cbc908432d3 | 2020-06-01 | Warnings, Adverse reactions | HALOBETASOL PROPIONATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.